# Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

> **NCT00197145** · PHASE3 · TERMINATED · sponsor: **ViiV Healthcare** · enrollment: 24 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus I

## Interventions

- **DRUG:** GW873140

## Key facts

- **NCT ID:** NCT00197145
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07-21
- **Primary completion:** 2007-09-11
- **Final completion:** 2007-09-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197145, "Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00197145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*